Erratum to "Brief Report: Canadian Cancer Trials Group IND.227: A Phase II randomized study of pembrolizumab in patients with advanced malignant pleural mesothelioma (NCT02784171). [Journal of Thoracic Oncology Vol. 18 No. 6: 813-819]"
1 Clinical Trials Unit, Istituto Nazionalei Tumori Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Fondazione G. Pascale, Napoli, Italy.
2 Cross Cancer Institute, Edmonton, Alberta, Canada.
3 University Health Network, Toronto, Ontario, Canada.
4 Canadian Cancer Trials Group, Kingston, Ontario, Canada.
5 Mesothelioma Unit (FG) & Department of Integrated Activities Research and Innovation (FU), SS. Antonio e Biagio C. Arrigo Hospital, Alessandria, Italy.
6 Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, Quebec, Canada.
7 Oncology Unit ASL 3, Villa Scassi Hospital, Genova, Italy.
8 Juravinski Cancer Centre, Ontario, Canada.
9 Medical Oncology, Comprehensive Cancer Centre, AUSL Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) of Reggio Emilia, Reggio Emilia, Italy.
10 Oncology and Hematology Unit, University of Campania "Luigi Vanvitelli," Naples, Italy.
11 Oncology Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituti Fisioterapici Ospitalieri (IFO) Istituto Regina Elena, Rome, Italy.
12 London Regional Cancer Program, London, Ontario, Canada.
13 Thoracic Oncology Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale Tumori, Milano, Italy.
14 Department of Medical Oncology and Hematology, CancerCare Manitoba, Winnipeg, Canada.
15 Tom Baker Cancer Centre and Cumming School of Medicine, Calgary, Alberta, Canada.
16 British Columbia Cancer Agency, Surrey, British Columbia, Canada.
17 Thoracic Oncology Unit, Istituto Nazionale Tumori Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Fondazione G. Pascale, Napoli, Italy.
18 Oncology Unit, S. Giuseppe Moscati Hospital, Avellino, Italy.
19 Oncology and Hematology Department, USL Piacenza, Gugliemimo da Saliceto Hospital, Piacenza, Italy.
20 Allan Blair Cancer Centre, Regina, Saskatchewan, Canada.
21 Ottawa Hospital Research Institute and Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.